TP, M., R, N., F, F., A, G., E, H., J, C., . . . J, F. (2023). Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. Frontiers in immunology, 14, 1216225. https://doi.org/10.3389/fimmu.2023.1216225
Chicago Style (17th ed.) CitationTP, Monath, et al. "Immunological Correlates of Protection Afforded by PHV02 Live, Attenuated Recombinant Vesicular Stomatitis Virus Vector Vaccine Against Nipah Virus Disease." Frontiers in Immunology 14 (2023): 1216225. https://doi.org/10.3389/fimmu.2023.1216225.
MLA (9th ed.) CitationTP, Monath, et al. "Immunological Correlates of Protection Afforded by PHV02 Live, Attenuated Recombinant Vesicular Stomatitis Virus Vector Vaccine Against Nipah Virus Disease." Frontiers in Immunology, vol. 14, 2023, p. 1216225, https://doi.org/10.3389/fimmu.2023.1216225.